Although the Black population is about 17% of the world population (over one billion), Blacks are disproportionately affected by cancer globally. Given the disproportionate burden of cancer in Blacks, it is important to have a significant number of Blacks participate in cancer clinical trials globally. Unfortunately, the accrual of Blacks all over the world in clinical research remains low despite ongoing attempts to improve their participation. The under-representation of Blacks in clinical trials continues to magnify the cancer health disparities experienced by this group. Unfortunately, overcoming the barriers for successful clinical trial enrollment of Blacks continues to be a significant challenge. The Global Congress on Oncology Clinical Trials in Blacks is proposed to address the underrepresentation of Blacks in clinical trials.
Inaugural Global Congress on Oncology Clinical Trials in Blacks